4//SEC Filing
Albright Charles 4
Accession 0001179110-20-010507
CIK 0001650664other
Filed
Oct 15, 8:00 PM ET
Accepted
Oct 16, 4:38 PM ET
Size
5.0 KB
Accession
0001179110-20-010507
Insider Transaction Report
Form 4
Albright Charles
Chief Scientific Officer
Transactions
- Sale
Common Stock
2020-10-15$31.39/sh−3,000$94,170→ 25,135 total
Footnotes (2)
- [F1]The sale reported in this Form 4 was effected pursuant to a 10b5-1 plan adopted by the Reporting Person on May 15, 2020.
- [F2]This transaction was executed in multiple trades at prices ranging from $30.88 to $31.77. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Documents
Issuer
Editas Medicine, Inc.
CIK 0001650664
Entity typeother
Related Parties
1- filerCIK 0001682323
Filing Metadata
- Form type
- 4
- Filed
- Oct 15, 8:00 PM ET
- Accepted
- Oct 16, 4:38 PM ET
- Size
- 5.0 KB